Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verve Therapeutics

11.28
+0.07000.62%
Post-market: 11.24-0.0385-0.34%16:20 EDT
Volume:1.14M
Turnover:12.84M
Market Cap:1.01B
PE:-5.37
High:11.29
Open:11.23
Low:11.22
Close:11.21
Loading ...

Verve Therapeutics Cut to Market Perform From Outperform by BMO Capital

Dow Jones
·
28 Jun

BMO Capital Downgrades Verve Therapeutics to Market Perform, $13.50 Price Target

MT Newswires Live
·
27 Jun

Verve Therapeutics Inc : Bmo Cuts to Market Perform From Outperform; Cuts Target Price to $13.50 From $20.00

THOMSON REUTERS
·
27 Jun

Hold Rating Issued for Verve Therapeutics Amid Eli Lilly Acquisition and Uncertain Milestones

TIPRANKS
·
27 Jun

Verve Therapeutics downgraded to Market Perform from Outperform at BMO Capital

TIPRANKS
·
27 Jun

Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week

Motley Fool
·
21 Jun

J.P. Morgan Remains a Hold on Verve Therapeutics (VERV)

TIPRANKS
·
19 Jun

Eli Lilly (LLY) Enters Gene-Editing Space with Verve Therapeutics Acquisition

TIPRANKS
·
19 Jun

HC Wainwright Downgrades Verve Therapeutics to Neutral From Buy, $25 Price Target

MT Newswires Live
·
18 Jun

Verve Therapeutics Inc : H.c. Wainwright Cuts to Neutral Rating

THOMSON REUTERS
·
18 Jun

Hold Rating on Verve Therapeutics Acquisition by Eli Lilly: Fair Valuation with Low Competing Bid Potential

TIPRANKS
·
18 Jun

Verve Therapeutics downgraded to Neutral from Buy at H.C. Wainwright

TIPRANKS
·
18 Jun

Verve Therapeutics Inc : Jefferies Cuts to Hold From Buy; Cuts Target Price to $11 From $28

THOMSON REUTERS
·
18 Jun

Verve Therapeutics Inc : JP Morgan Cuts Target Price to $12.00 From $16.00

THOMSON REUTERS
·
18 Jun

Verve Therapeutics downgraded to Market Perform from Outperform at LifeSci

TIPRANKS
·
18 Jun

Hold Rating on Verve Therapeutics Amid Acquisition and Development Milestones

TIPRANKS
·
18 Jun

Verve Therapeutics (VERV) Receives a Buy from BMO Capital

TIPRANKS
·
18 Jun

Sector Update: Health Care Stocks Fall in Afternoon Trading

MT Newswires Live
·
18 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Red Cat, Nvidia Corp, Redwire

Reuters
·
18 Jun

Verve Therapeutics Cut to Hold From Buy by Canaccord Genuity

Dow Jones
·
17 Jun